LogicBio

Read more
Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating

82/100

Founded:

2014

Status:

PublicIndependent CompanyNASDAQLOGC

LOGICBIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

LogicBio's company profile
Frederic Chereau's photo - President & CEO of LogicBio

Frederic Chereau

President & CEO

82/100
23
$149.5M
$3.7M
View Profile
1
LogicBio's Competitor - Sangamo logo
Sandy Macrae's photo - President & CEO of Sangamo

Sandy Macrae

President & CEO

77/100
302
$71.5M
$137.7M
View Profile
2
LogicBio's Competitor - bluebird bio logo
Nick Leschly's photo - President & CEO of bluebird bio

Nick Leschly

President & CEO

71/100
764
$526.4M
$50.2M
View Profile
3
LogicBio's Competitor - Recombinetics logo
Mark Platt's photo - CEO of Recombinetics

Mark Platt

CEO

82/100
45
$73.7M
$7.2M
View Profile
4
LogicBio's Competitor - REGENXBIO logo
Kenneth Mills's photo - President & CEO of REGENXBIO

Kenneth Mills

President & CEO

95/100
192
$244.5M
$161.3M
View Profile
5
LogicBio's Competitor - InterMune logo
Daniel G. Welch's photo - President & CEO of InterMune

Daniel G. Welch

President & CEO

65/100
269
$125M
$300M
View Profile
6
LogicBio's Competitor - Renova Therapeutics logo
Roy Cosan's photo - Interim-CEO of Renova Therapeutics

Roy Cosan

Interim-CEO

88/100
35
$7.5M
$4.8M
View Profile
7
LogicBio's Competitor - Immunocore logo
Bahija Jallal's photo - CEO of Immunocore

Bahija Jallal

CEO

90/100
291
$923.3M
$40.9M
View Profile
8
LogicBio's Competitor - Intellia logo
John Leonard's photo - President & CEO of Intellia

John Leonard

President & CEO

84/100
211
$883M
$41.8M
View Profile
9
LogicBio's Competitor - uniQure logo
Matthew Kapusta's photo - CEO of uniQure

Matthew Kapusta

CEO

83/100
332
$163.1M
$500.2M
View Profile
10
LogicBio's Competitor - CRISPR logo
Samarth Kulkarni's photo - CEO of CRISPR

Samarth Kulkarni

CEO

97/100
410
$183M
$901.8M
View Profile
11
LogicBio's Competitor - Ember Therapeutics logo
CEO Avatar

CEO

- -
3
$1M
$6.4M
View Profile
12
LogicBio's Competitor - Asklepios logo
Kai Hankeln's photo - CEO of Asklepios

Kai Hankeln

CEO

72/100
67,000
$652M
$5.3B
View Profile

Missing a competitor? Contribute!

Sangamo is seen as one of LogicBio's top competitors. Sangamo was founded in Brisbane, California} in 1995. Sangamo is in the Biotechnology industry. Compared to LogicBio, Sangamo generates $134M more revenue.

bluebird bio is LogicBio's #2 competitor. bluebird bio was founded in 1992, and its headquarters is in Cambridge, Massachusetts. bluebird bio competes in the Biotechnology industry. bluebird bio has 1,190 more employees than LogicBio.

Recombinetics is LogicBio's #3 rival. Recombinetics is headquartered in Saint Paul, Minnesota, and was founded in 2008. Like LogicBio, Recombinetics also competes in the Biotechnology industry. Recombinetics generates 194% the revenue of LogicBio.

LogicBio Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.7M

LogicBio's revenue is the ranked 23th among it's top 10 competitors. The top 10 competitors average 3.4B. Over the last four quarters, LogicBio's revenue has decreased by 13.4%. Specifically, in Q2 2021's revenue was $ < 1M; in Q1 2021, it was $ < 1M; in Q4 2020, it was $1.5M; in Q3 2020, LogicBio's revenue was $ < 1M.

LogicBio Acquisitions

No recent acquisitions found related to LogicBio

LogicBio Funding History

Since LogicBio was founded in 2014, it has participated in 4 rounds of funding. In total LogicBio has raised $149.5M. LogicBio's last funding round was on Jul 2019 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2019
$20M
IPO
Oct 2018
$80.5M
-
Series B
Jun 2017
$45M
Equity
Jan 2016
$4M

Since LogicBio was founded in 2014, it has participated in 4 rounds of funding. In total LogicBio has raised $149.5M. LogicBio's last funding round was on Jul 2019 for a total of $20.0M

LogicBio Investments

No recent investments found related to LogicBio

LogicBio News

August 9, 2021Zacks

LogicBio Therapeutics (LOGC) Reports Q2 Loss, Lags Revenue Estimates

LogicBio Therapeutics (LOGC) delivered earnings and revenue surprises of -32.00% and -83.99%, respect... See more »
June 2, 2021MarketScreener

Company remains on track to announce update on enrollment, dose escalation and age de-escalation in late 2021 and interim data by year-end 2021 (Form 8-K)

(marketscreener.com) - Company remains on track to announce update on enrollment, dose escalation and... See more »
May 14, 2021MarketScreener

2021 ASGCT Annual Meeting - Crigler-Najjar

(marketscreener.com) Optimization of GeneRide-Encoding UGT1A1 Vector Improved Efficacy in a Mouse Mod... See more »
May 12, 2021MarketScreener

ASGCT 2021

(marketscreener.com) A Novel Liver-Tropic AAV Capsid sL65 Shows Superior Transduction and Efficacy in... See more »
May 3, 2021MarketScreener

2021 ACMG Annual Meeting - Methylmalonic Acidemia

(marketscreener.com) eP034 Retrospective Study of the Disease Course in Pediatric Patients With Sever... See more »
April 27, 2021The Pharma Letter

LogicBio out-licenses LB-001 in Greater China; inks deal in Japan

USA-based LogicBio Therapeutics has announced a strategic collaboration and option agreement with Chi... See more »

LogicBio Press Releases

May 3, 2021centralcharts

LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic Acidemia

LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with S... See more »
April 27, 2021PR Newswire

LogicBio Therapeutics Announces Clinical and Corporate Updates

LEXINGTON, Mass., April 27, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinica... See more »
January 7, 2021PR Newswire

LogicBio Announces Extension Of Collaboration With Children's Medical Research Institute

LEXINGTON, Mass., Jan. 7, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (LogicBio - Nasdaq: LOGC),... See more »
November 4, 2020GlobeNewswire

LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA)

Fast Track designation facilitates development of new therapies that treat serious conditions and ful... See more »
May 28, 2020centralcharts

LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference

LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »
May 11, 2020GlobeNewswire

LogicBio Reports First Quarter 2020 Financial Results and Provides Business Updates

LEXINGTON, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »

Social Media

LogicBio Headquarters

-

Cambridge, Massachusetts-

Driving Directions »

Trending Companies

LogicBio Summary

ABOUT

Overview

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. LogicBio was founded in 2014. LogicBio's headquarters is located in Cambridge, Massachusetts, USA -. LogicBio's President & CEO, Frederic Chereau, c...

CEO

LogicBio's President & CEO, Frederic Chereau, currently has an approval rating of 82%. LogicBio's primary competitors are Sangamo, bluebird bio & Recombinetics.

Frequently Asked Questions about LogicBio

  1. When was LogicBio founded?

    LogicBio was founded in 2014
  2. Who is LogicBio's CEO?

    LogicBio's CEO is Frederic Chereau
  3. How much revenue does LogicBio generate?

    LogicBio generates $3.7M in revenue
  4. How much funding does LogicBio have?

    LogicBio has historically raised $149.5M in funding
  1. Where is LogicBio's headquarters?

    LogicBio's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does LogicBio have?

    LogicBio has 23 employees
  3. What sector does LogicBio operate in?

    LogicBio is in Biotechnology
  4. Who are LogicBio's competitors?

    LogicBio's top competitors are Sangamo, bluebird bio, Recombinetics